Portfolio company
Serotiny
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops therapeutic multi-domain proteins for pharmaceutical and life sciences firms to enhance gene and cell therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SE Therapeutics
This biotechnology firm develops self-delivering protein platforms for gene and cell therapy manufacturers treating chronic, rare and neurological diseases.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Synteny Biotechnology
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
Protuoso Biosciences
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
Anjarium BioSciences
This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.
Catena Bio
This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.
Kyron.bio
This company develops glycan-engineering technology to improve therapeutic proteins and antibodies for pharmaceutical firms and research institutions.
